Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.18 -0.23 (-3.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Gains from Investment Securities (2016 - 2026)

Updated

Analysis

Cartesian Therapeutics (RNAC) Gains from Investment Securities (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Cartesian Therapeutics 185.63 Mn -349.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.54 Mn
Mar 31, 2024 -6.89 Mn
Dec 31, 2023 -149.60 Mn
Dec 31, 2022 29,000.00
Dec 31, 2021 1,000.00
Mar 31, 2021 -1,000.00
Sep 30, 2019 -2,000.00
Jun 30, 2019 1,000.00
Mar 31, 2019 2,000.00
Sep 30, 2018 1,000.00
Jun 30, 2018 12,000.00
Mar 31, 2018 3,000.00
Dec 31, 2017 -11,000.00
Sep 30, 2017 6,000.00
Jun 30, 2017 10,000.00
Mar 31, 2017 15,000.00
Dec 31, 2016 -52,000.00
Sep 30, 2016 16,000.00
API Access

Cartesian Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RNAC&period=max&api_key=YOUR_API_KEY